Skip to main content
. 2021 Feb 11;16(2):e0246463. doi: 10.1371/journal.pone.0246463

Fig 3. Safety of diazoxide in patients with hyperinsulinemic hypoglycemia.

Fig 3

(A) Edema; (B) fluid retention; (C) gastrointestinal reaction; (D) hypertrichosis; (E) neutropenia; (F) pulmonary hypertension; and (G) thrombocytopenia.